Stemedica Cell Technologies, Inc. Release: WSCS14 Poster Forum Winners Announced

SAN ANTONIO (December 5, 2014) The winners of the World Stem Cell Summit Poster Prize were announced Friday morning. Stemedica Cell Technologies, Inc., a leader in adult allogeneic stem cell manufacturing, research and clinical development, sponsored $5,000 in cash prizes for the winners.

Posters were assessed based on creativity, scientific method, contribution to science and/or medicine and communicative power. Three posters won stem cell research prizes prizes, and two additional posters garnered special mentions for a total of five winners. First place was awarded to “Modulation of T Cells by Mesenchymal Stem Cells via Control of CD25,” from Rutgers University; second place to “Inhibition of PDGFRa+ Sca-1+ Mesenchymal Progenitor Proliferation and Differentiation By Nilotinib Leads to Improved Cardiac Function Following Ischemic Injury,” from University of British Columbia; and third place to “The Medical Student Stem Cell Club: A Community Initiative Enhancing Stem Cell Donor Recruitment,” also from University of British Columbia.

The World Stem Cell Summit Poster Forum is the only interdisciplinary stem cell poster session covering all topics in regenerative medicine. Posters display today’s most innovative science, leading-edge technologies, industry updates, regulatory and patient advocacy solutions. All of the 2014 World Stem Cell Summit Poster Abstracts, including the winners’, are available for download on the Poster Forum page of, or online here (pdf).

This year’s judges were from Kyoto University, Mayo Clinic, Karolinska University Hospital, Karolinska Institute, The Scripps Research Institute and University of Texas Health Science Center at San Antonio. The five-member panel included:

Takashi Asada, PhD, Professor, Field of Stem Cell Research, Institute for Frontier Medical Sciences, Kyoto University, Tokyo, Japan

Matthias Corbascio, MD, PhD, Consultant Cardiothoracic Surgery, Department of Cardiothoracic Surgery and Anesthesiology, Karolinska University Hospital, Solna Vice President, IsletOne Therapeutics, Stockholm, Sweden

Karl-Henrik Grinnemo, MD, Group Leader in Regenerative Cardiology, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden

Jeanne F. Loring, PhD, Professor of Developmental Neurobiology, Director of the Center for Regenerative Medicine, Department of Chemical Physiology California Campus, The Scripps Research Institute, La Jolla, CA

Mary Pat Moyer, PhD, Founder, CEO and Chief Science Officer INCELL Corporation, LLC, Clinical Professor, Department of Surgery University of Texas Health Science Center at San Antonio, San Antonio, TX

Co-Authors and abstracts are posted on the World Stem Cell Summit Poster Forum web site. The WSCS14 Poster Forum Prize Winners are:

Gold Prize (Stem Cell Research) – “Landscape of a novel RNA binding protein L1TD1 protein-protein interactome in human Pluripotency,” Primary Author: Maheswara Reddy Emani, Post Doctoral Fellow, Turku Centre for Biotechnology, University of Turku. Turun yliopisto, Finland.

Silver Prize (Stem Cell Research) – “Engineering of Macaque CD4+ T Cells and CD34+ Hematopoietic Stem Cells resistant to in vitro SIV Infection using Zinc Finger Nucleases Technology,” Primary Author: Marie-Claire Gauduin, Associate Scientist, Texas Biomedical Research Institute, Department of Virology and Immunology.

Bronze Prize (Stem Cell Research) – “Pilot Analysis of Cartilage Implant with Genetically Modified Adipose Mesenchymal Stem Cells with the IGF-1 Gene in Ovis aries,” Primary Author: Alejandra M. Galván-De los Santos, MD, Departamento de Bioquímica y Medicina Molecular, Facultad de Medicina, Universidad Autónoma de Nuevo León (UANL), Centro de Investigación y Desarrollo en Ciencias de la UANL (CIDC), Monterrey, Mexico.

Regenerative Medicine Prize – “Matrix Proteins and Retina Development in a 3-D in-vitro system,” Primary Author: Hetty Wang, PhD, United States Army.

Patient Advocacy – “Huntington’s Disease – 21 Years of Fast-Track Stem Cell Research Makes the Hope for a Treatment a Reality,” Primary Author: Frances D. Saldana, Patient Advocate, Huntington’s Disease Community Advocacy, Research & Education, President, HD-Care, The Mind Institute, University of California, Irvine.

Help employers find you! Check out all the jobs and post your resume.

Back to news